Combining digital adherence technology and therapeutic drug monitoring for personalised TB care

Samiksha Ghimire; Deni Iskandar; Roelina van der Borg-Boekhout; Marina Zenina; Mathieu S Bolhuis; Huib A M Kerstjens; Marieke van Rossum; Daan J Touw; Tanja R Zijp; Job F M van Boven; Onno W Akkerman

doi:10.1183/13993003.01690-2022

Combining digital adherence technology and therapeutic drug monitoring for personalised TB care

Samiksha Ghimire, Deni Iskandar, Roelina van der Borg-Boekhout, Marina Zenina, Mathieu S Bolhuis, Huib A M Kerstjens, Marieke van Rossum, Daan J Touw, Tanja R Zijp, Job F M van Boven^*, Onno W Akkerman

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

1 Citaat (Scopus)

29 Downloads (Pure)

Samenvatting

Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Notably, proper treatment adherence is essential for successful treatment outcome [1, 2]. To improve adherence, counseling and education are important. For specific patient groups, such as those with drug-resistant TB, HIV co-infection and those on intermittent treatment regiments, the World Health Organization (WHO) advises to use the Directly Observed Treatment (DOT) strategy. However, even with DOT, treatment completion is still challenging and cure rates and outcomes remain suboptimal [3].

Originele taal-2	English
Artikelnummer	2201690
Aantal pagina's	4
Tijdschrift	European Respiratory Journal
Volume	60
Vroegere onlinedatum	10-nov.-2022
DOI's	https://doi.org/10.1183/13993003.01690-2022
Status	Published - 2022

Toegang tot document

10.1183/13993003.01690-2022

Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis careFinal publisher's version, 370 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

Ghimire, S., Iskandar, D., van der Borg-Boekhout, R., Zenina, M., Bolhuis, M. S., Kerstjens, H. A. M., van Rossum, M., Touw, D. J., Zijp, T. R., van Boven, J. F. M., & Akkerman, O. W. (2022). Combining digital adherence technology and therapeutic drug monitoring for personalised TB care. European Respiratory Journal, 60, Artikel 2201690. https://doi.org/10.1183/13993003.01690-2022

@article{8bb8472259234c5c8b7b3c64e2d99807,

title = "Combining digital adherence technology and therapeutic drug monitoring for personalised TB care",

abstract = "Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Notably, proper treatment adherence is essential for successful treatment outcome [1, 2]. To improve adherence, counseling and education are important. For specific patient groups, such as those with drug-resistant TB, HIV co-infection and those on intermittent treatment regiments, the World Health Organization (WHO) advises to use the Directly Observed Treatment (DOT) strategy. However, even with DOT, treatment completion is still challenging and cure rates and outcomes remain suboptimal [3].",

keywords = "MEDICATION ADHERENCE, TUBERCULOSIS, EHEALTH, Digital health technology, MHEALTH, Digital, SALIVA, RIFAMPICIN",

author = "Samiksha Ghimire and Deni Iskandar and {van der Borg-Boekhout}, Roelina and Marina Zenina and Bolhuis, {Mathieu S} and Kerstjens, {Huib A M} and {van Rossum}, Marieke and Touw, {Daan J} and Zijp, {Tanja R} and {van Boven}, {Job F M} and Akkerman, {Onno W}",

year = "2022",

doi = "10.1183/13993003.01690-2022",

language = "English",

volume = "60",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",

}

TY - JOUR

T1 - Combining digital adherence technology and therapeutic drug monitoring for personalised TB care

AU - Ghimire, Samiksha

AU - Iskandar, Deni

AU - van der Borg-Boekhout, Roelina

AU - Zenina, Marina

AU - Bolhuis, Mathieu S

AU - Kerstjens, Huib A M

AU - van Rossum, Marieke

AU - Touw, Daan J

AU - Zijp, Tanja R

AU - van Boven, Job F M

AU - Akkerman, Onno W

PY - 2022

Y1 - 2022

N2 - Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Notably, proper treatment adherence is essential for successful treatment outcome [1, 2]. To improve adherence, counseling and education are important. For specific patient groups, such as those with drug-resistant TB, HIV co-infection and those on intermittent treatment regiments, the World Health Organization (WHO) advises to use the Directly Observed Treatment (DOT) strategy. However, even with DOT, treatment completion is still challenging and cure rates and outcomes remain suboptimal [3].

AB - Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Notably, proper treatment adherence is essential for successful treatment outcome [1, 2]. To improve adherence, counseling and education are important. For specific patient groups, such as those with drug-resistant TB, HIV co-infection and those on intermittent treatment regiments, the World Health Organization (WHO) advises to use the Directly Observed Treatment (DOT) strategy. However, even with DOT, treatment completion is still challenging and cure rates and outcomes remain suboptimal [3].

KW - MEDICATION ADHERENCE

KW - TUBERCULOSIS

KW - EHEALTH

KW - Digital health technology

KW - MHEALTH

KW - Digital

KW - SALIVA

KW - RIFAMPICIN

U2 - 10.1183/13993003.01690-2022

DO - 10.1183/13993003.01690-2022

M3 - Letter

C2 - 36356974

SN - 0903-1936

VL - 60

JO - European Respiratory Journal

JF - European Respiratory Journal

M1 - 2201690

ER -